Early Results of a Phase II Study of Ofatumumab As Front-Line Treatment in Elderly, Unfit Patients with Chronic Lymphocytic Leukemia (CLL)

被引：1

作者：

Ciccone, Maria ^{[1
]}

Vitale, Candida ^{[1
]}

Hinojosa, Christina ^{[1
]}

Keating, Michael J. ^{[1
]}

Pemmaraju, Naveen ^{[1
]}

O'Brien, Susan ^{[1
]}

Burger, Jan A. ^{[1
]}

Thomas, Deborah A. ^{[1
]}

Kantarjian, Hagop M. ^{[1
]}

Strati, Paolo ^{[1
]}

Wierda, William G. ^{[1
]}

Ferrajoli, Alessandra ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

10.1182/blood.V124.21.5656.5656

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] Ofatumumab as front-line treatment in elderly unfit patients with chronic lymphocytic leukemia
Vitale, Candida
Ciccone, Maria
Hinojosa, Christina
Keating, Michael J.
Pemmaraju, Naveen
O'Brien, Susan
Wierda, William G.
Thomas, Deborah H.
Borthakur, Gautam
Ohanian, Maro
Burger, Jan A.
Ferrajoli, Alessandra
LEUKEMIA & LYMPHOMA, 2015, 56 : 144 - 145
[2] Front-Line Treatment with Ofatumumab for Older Unfit Patients with Chronic Lymphocytic Leukemia
Vitale, Candida
Ciccone, Maria
Hinojosa, Christina
Keating, Michael
Pemmaraju, Naveen
O'Brien, Susan
Wierda, William
Thomas, Deborah A.
Borthakur, Gautam
Ohanian, Maro
Burger, Jan A.
Ferrajoli, Alessandra
BLOOD, 2015, 126 (23)
[3] Chronic Lymphocytic Leukemia: A Review of Front-line Treatment Options, With a Focus on Elderly CLL Patients
O'Reilly, Alma
Murphy, James
Rawe, Sarah
Garvey, Mary
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04): : 249 - 256
[4] Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemia
Reagan, John L.
Castillo, Jorge J.
FUTURE ONCOLOGY, 2014, 10 (07) : 1147 - 1155
[5] FRONT-LINE THERAPY WITH CHLORAMBUCIL PLUS RITUXIMAB IN ELDERLY AND/OR UNFIT PATIENTS AFFECTED BY CHRONIC LYMPHOCYTIC LEUKEMIA
Innocenti, I.
Tarnani, M.
Vannata, B.
De Padua, L.
Santini, F.
Marietti, S.
Za, T.
Bellesi, S.
Autore, F.
Chiusolo, P.
Sora, F.
Sica, S.
Leone, G.
Laurenti, L.
HAEMATOLOGICA, 2012, 97 : 523 - 524
[6] Combination of Ofatumumab and Lenalidomide in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): Results of a Phase II Trial
Ferrajoli, Alessandra
Falchi, Lorenzo
O'Brien, Susan
Wierda, William
Faderl, Stefan
Smith, Susan C.
Ayala, Ana B.
Kantarjian, Hagop M.
Keating, Michael J.
BLOOD, 2012, 120 (21)
[7] EFFICACY AND SAFETY OF FRONT-LINE TREATMENT WITH IBRUTINIB AND RITUXIMAB IN UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). FIRST REPORT OF THE GIMEMA LLC1114 STUDY
Mauro, F. R.
Molica, S.
Paoloni, F.
Reda, G.
Trentin, L.
Marchetti, M.
Pietrasanta, D.
Coscia, M.
Marasca, R.
Sportoletti, P.
Gaidano, G.
Orsucci, L.
Stelitano, C.
Di Renzo, N.
Liberati, M.
Gottardi, D.
Re, F.
Ilariucci, F.
Zinzani, P. L.
Mannina, D.
Gozzetti, A.
Molinari, A. L.
Gentile, M.
Chiarenza, A.
Laurenti, L.
Varettoni, M.
Ibatici, A.
Murru, R.
Tani, M.
De Propris, M. S.
Del Giudice, I.
Della Starza, I.
Raponi, S.
Nanni, M.
Fazi, P.
Crea, E.
Neri, A.
Specchia, G.
Guarini, A.
Cuneo, A.
Foa, R.
HAEMATOLOGICA, 2019, 104 : 18 - 19
[8] Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Cortes, Jorge E.
Jones, Dan
O'Brien, Susan
Jabbour, Elias
Konopleva, Marina
Ferrajoli, Alessandra
Kadia, Tapan
Borthakur, Gautam
Stigliano, Denise
Shan, Jianqin
Kantarjian, Hagop
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 392 - 397
[9] Progress in the treatment of elderly/unfit chronic lymphocytic leukemia patients: results of the German CLL-11 trial
Molica, Stefano
EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (01) : 9 - 15
[10] Combination Therapy with Ofatumumab and Lenalidomide in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): Results of a Phase II Trial
Ferrajoli, Alessandra
O'Brien, Susan
Wierda, William G.
Faderl, Stefan
Badoux, Xavier
Estrov, Zeev
Schlette, Ellen
Smith, Susan C.
Ayala, Ana B.
Falchi, Lorenzo
Calin, Steliana
Kantarjian, Hagop M.
Keating, Michael J.
BLOOD, 2011, 118 (21) : 780 - 780

← 1 2 3 4 5 →